SIG | Epilepsy Surgery: Controversies in Thalamic Neuromodulation

Monday, December 7, 2026 at 2:00 PM to 3:30 PM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

Patients with drug-resistant epilepsy (DRE) who are not candidates for resective or ablative surgery are often considered for open- and closed-loop neuromodulation. This is more commonly being done with SEEG guidance. Various thalamic nuclei have been extensively investigated as targets for neuromodulation. However, choosing which nucleus to implant and which biomarker to guide neuromodulation are a pertinent topic of debate. We propose a combination debate style and moderated panel discussion by experts leading the field of thalamic neuromodulation.
Learning Objective 1
Understand how SEEG neurophysiological and stimulation data can help guide neuromodulation implantation
Learning Objective 2
Determine the advantages and disadvantages of different biomarkers in closed-loop neuromodulation as it compares to focused ultrasound
Learning Objective 3
Evaluate ethical challenges of thalamic SEEG implantation as it relates to research versus standard of care
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesBehavioral Health ProvidersNursesScientists/ResearchersSocial WorkersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session ID
SURGERYSIG26
Presentation Id
3452237
Event ID
24056
Session Type
Session